Product NDC: | 55390-500 |
Proprietary Name: | Bumetanide |
Non Proprietary Name: | Bumetanide |
Active Ingredient(s): | .25 mg/mL & nbsp; Bumetanide |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-500 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074441 |
Marketing Category: | ANDA |
Start Marketing Date: | 19950301 |
Package NDC: | 55390-500-02 |
Package Description: | 10 VIAL in 1 BOX (55390-500-02) > 2 mL in 1 VIAL |
NDC Code | 55390-500-02 |
Proprietary Name | Bumetanide |
Package Description | 10 VIAL in 1 BOX (55390-500-02) > 2 mL in 1 VIAL |
Product NDC | 55390-500 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Bumetanide |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19950301 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | BUMETANIDE |
Strength Number | .25 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |